TRAIL–NP hybrids for cancer therapy: a review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRAIL–NP hybrids for cancer therapy: a review

Published:2017 Issue:18 Volume:9 Page:5755-5768
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Belkahla H.,Herlem G.,Picaud F.,Gharbi T.,Hémadi M.^ORCID,Ammar S.,Micheau O.^ORCID

Funder

Agence Nationale de la Recherche

Association pour la Recherche sur le Cancer

Institut National Du Cancer

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2017/NR/C7NR01469D

Reference225 articles.

1. Defining the critical hurdles in cancer immunotherapy

2. Safety and antitumor activity of recombinant soluble Apo2 ligand

3. Transduction of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand into Hematopoietic Cells Leads to Inhibition of Syngeneic Tumor Growth In vivo

4. Death receptors as targets in cancer

5. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD13-targeting and TRAIL-displaying protein nanoparticles effectively induce apoptotic cell death of acute myeloid leukemia, prolonging survival in mouse models;Nano Today;2024-12

2. Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review;Heliyon;2024-08

4. Superior TRAIL gene expression and cancer cell apoptosis mediated by highly branched-linear poly(β-amino ester)s;Journal of Nanobiotechnology;2023-10-28

5. Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles;ACS Materials Au;2023-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3